Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueyan He

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Scientific Reports|December 22, 2022
Author Correction: Iraq/Afghanistan war lung injury reflects burn pits exposureTimothy Olsen, Dennis Caruana, Keely Cheslack-Postava, et al.
Scientific Reports|August 29, 2022
Iraq/Afghanistan war lung injury reflects burn pits exposureTimothy Olsen, Dennis Caruana, Keely Cheslack-Postava, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Cancer Research|September 28, 2021
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer ProgressionCuicui Liu, Jiankun Qiang, Qiaodan Deng, et al.
Nature Communications|July 21, 2021
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancerJiahui Xu, Xiaoli Yang, Qiaodan Deng, et al.
Plos Biology|July 28, 2018
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancerWeilong Chen, Yuanyuan Qin, Dong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2024
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBCQiaodan Deng, Jiankun Qiang, Cuicui Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 StabilityLixing Zhang, Jiankun Qiang, Xiaoli Yang, et al.
Cancer Research|April 24, 2024
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast CancerJie Xia, Lixing Zhang, Xilei Peng, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Signal Transduction and Targeted Therapy|March 1, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathwayRui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Scientific Reports|December 22, 2022
Author Correction: Iraq/Afghanistan war lung injury reflects burn pits exposureTimothy Olsen, Dennis Caruana, Keely Cheslack-Postava, et al.
Scientific Reports|August 29, 2022
Iraq/Afghanistan war lung injury reflects burn pits exposureTimothy Olsen, Dennis Caruana, Keely Cheslack-Postava, et al.
Journal for Immunotherapy of Cancer|May 25, 2022
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarizationDandan Sheng, Wei Ma, Rui Zhang, et al.
Cancer Research|September 28, 2021
ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer ProgressionCuicui Liu, Jiankun Qiang, Qiaodan Deng, et al.
Nature Communications|July 21, 2021
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancerJiahui Xu, Xiaoli Yang, Qiaodan Deng, et al.
Plos Biology|July 28, 2018
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancerWeilong Chen, Yuanyuan Qin, Dong Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 12, 2024
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBCQiaodan Deng, Jiankun Qiang, Cuicui Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 StabilityLixing Zhang, Jiankun Qiang, Xiaoli Yang, et al.
Cancer Research|April 24, 2024
IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast CancerJie Xia, Lixing Zhang, Xilei Peng, et al.
Pageof 4